Tandlægeselskabet Overgaden I/S: Financial statements 2023
CVR: 31763207
Tandlægeselskabet Overgaden I/S (CVR 31763207) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,095,721 and a net result of DKK 305,464 compared with DKK 519,531 the year before. That is a decrease of 4.9% compared with the year before. Equity amounted to DKK 1,559,941. The solvency ratio was 57.7%. The company had 3 employees in the financial year.
- Gross Profit
- 2,095,721 kr.
- Profit/Loss
- 305,464 kr.
- Equity
- 1,559,941 kr.
- Total Assets
- 2,701,900 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.1 mio. | 305 t. | 1.6 mio. | 3 |
| 2022 | - | 2.2 mio. | 520 t. | 1.6 mio. | 4 |
| 2021 | - | 2.1 mio. | 176 t. | 1.3 mio. | 4 |
| 2020 | - | 2 mio. | 222 t. | 1.2 mio. | 4 |
| 2019 | - | 2.5 mio. | 580 t. | 1.2 mio. | 4 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Tandlægeselskabet Overgaden I/S has published its annual report for 2022. Gross profit came to DKK 2,204,624, and the net result was DKK 519,531.
About Tandlægeselskabet Overgaden I/S
Tandlægeselskabet Overgaden I/S is a Danish company of the type Interessentskab based in Børkop, founded in 2008. The company is registered under the industry Tandlægers aktiviteter. The management consists of Helle Søgaard Bøystrup and Mads Edeling. The company has 6 employees. In 2025, the company reported a gross profit of DKK 2,225,756 and a net result of DKK 230,388 compared with DKK 417,925 the year before. Equity amounted to DKK 1,677,212.
